Compare Agilent Technologies Inc (A) vs The Coca-Cola Co K (KO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs The Coca-Cola Co K — how do they compare? Agilent Technologies Inc trades at $129.05 (market cap $37.04B), while The Coca-Cola Co K trades at $83.3 (market cap $361.62B). The key difference: The Coca-Cola Co K is far larger — about 9.8× Agilent Technologies Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.52%). Which is the better fit depends on your goals.
| A | KO | |
|---|---|---|
Market Cap | $37.04B | $361.62B |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $84.14 |
52-Week Low | $110.24 | $65.67 |
Enterprise Value | $38.59B | $391.69B |
Dividend Yield | 0.78% | 2.52% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Coca-Cola (KO) trades at $83.89, up 1.12% today, with strong technical momentum and bullish moving averages. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $0.92. Revenue grew to $47.94B in 2025, with net income margin expanding to 27.8%. Recent news highlights institutional accumulation and stable demand trends ahead of earnings.
KO presents a favorable outlook with analyst consensus at Buy (60.42%) and a $88.14 price target, offering ~5% upside. Risks include regional demand divergence and high valuation multiples. The stock remains a core holding for dividend growth, having raised payouts for 64 consecutive years.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
